Ars Pharmaceuticals Stock Price Patterns
| SPRY Stock | 9.99 0.23 2.25% |
Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.35) | EPS Estimate Current Year (1.80) | EPS Estimate Next Year (1.47) | Wall Street Target Price 28 | EPS Estimate Current Quarter (0.49) |
Using ARS Pharmaceuticals hype-based prediction, you can estimate the value of ARS Pharmaceuticals from the perspective of ARS Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ARS Pharmaceuticals using ARS Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ARS using crowd psychology based on the activity and movement of ARS Pharmaceuticals' stock price.
ARS Pharmaceuticals Short Interest
An investor who is long ARS Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about ARS Pharmaceuticals and may potentially protect profits, hedge ARS Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 12.6483 | Short Percent 0.3333 | Short Ratio 11.35 | Shares Short Prior Month 20.5 M | 50 Day MA 10.1945 |
ARS Pharmaceuticals Hype to Price Pattern
Investor biases related to ARS Pharmaceuticals' public news can be used to forecast risks associated with an investment in ARS. The trend in average sentiment can be used to explain how an investor holding ARS can time the market purely based on public headlines and social activities around ARS Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ARS Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ARS Pharmaceuticals.
ARS Pharmaceuticals Implied Volatility | 1.79 |
ARS Pharmaceuticals' implied volatility exposes the market's sentiment of ARS Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ARS Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ARS Pharmaceuticals stock will not fluctuate a lot when ARS Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ARS Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying ARS because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ARS Pharmaceuticals after-hype prediction price | USD 9.97 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current ARS contract
Based on the Rule 16, the options market is currently suggesting that ARS Pharmaceuticals will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With ARS Pharmaceuticals trading at USD 9.99, that is roughly USD 0.0112 . If you think that the market is fully incorporating ARS Pharmaceuticals' daily price movement you should consider acquiring ARS Pharmaceuticals options at the current volatility level of 1.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out ARS Pharmaceuticals Basic Forecasting Models to cross-verify your projections. ARS Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of ARS Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ARS Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ARS Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ARS Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting ARS Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ARS Pharmaceuticals' historical news coverage. ARS Pharmaceuticals' after-hype downside and upside margins for the prediction period are 4.31 and 15.63, respectively. We have considered ARS Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ARS Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of ARS Pharmaceuticals is based on 3 months time horizon.
ARS Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ARS Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ARS Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ARS Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.40 | 5.66 | 0.02 | 0.20 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
9.99 | 9.97 | 0.20 |
|
ARS Pharmaceuticals Hype Timeline
ARS Pharmaceuticals is at this time traded for 9.99. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.2. ARS is projected to decline in value after the next headline, with the price expected to drop to 9.97. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.2%, whereas the daily expected return is at this time at 0.4%. The volatility of related hype on ARS Pharmaceuticals is about 1141.13%, with the expected price after the next announcement by competition of 10.19. About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.81. ARS Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 7 days. Check out ARS Pharmaceuticals Basic Forecasting Models to cross-verify your projections.ARS Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to ARS Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict ARS Pharmaceuticals' future price movements. Getting to know how ARS Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ARS Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GHRS | GH Research PLC | 0.16 | 9 per month | 4.10 | 0.07 | 6.76 | (8.53) | 40.50 | |
| NBTX | Nanobiotix | 0.19 | 11 per month | 5.46 | 0.05 | 9.21 | (6.07) | 32.10 | |
| ABUS | Arbutus Biopharma Corp | 0.62 | 6 per month | 0.00 | (0.03) | 5.10 | (4.71) | 20.16 | |
| LENZ | LENZ Therapeutics | 0.19 | 26 per month | 0.00 | (0.12) | 8.05 | (6.56) | 40.02 | |
| SVRA | Savara Inc | (0.11) | 11 per month | 2.97 | 0.1 | 8.25 | (4.98) | 24.50 | |
| RZLT | Rezolute | 0.19 | 10 per month | 15.23 | 0.03 | 18.05 | (9.22) | 99.29 | |
| KURA | Kura Oncology | 0.92 | 11 per month | 0.00 | (0.06) | 5.01 | (5.08) | 22.27 | |
| PROK | ProKidney Corp | (0.87) | 10 per month | 0.00 | (0.12) | 5.77 | (8.95) | 22.38 | |
| PVLA | Palvella Therapeutics | 4.54 | 10 per month | 4.68 | 0.05 | 8.80 | (8.04) | 28.65 | |
| TYRA | Tyra Biosciences | (0.87) | 6 per month | 1.60 | 0.28 | 6.05 | (2.98) | 34.11 |
ARS Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine ARS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ARS using various technical indicators. When you analyze ARS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ARS Pharmaceuticals Predictive Indicators
The successful prediction of ARS Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ARS Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ARS Pharmaceuticals based on analysis of ARS Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ARS Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ARS Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Payables Turnover | 1.87 | 2.56 | Days Of Inventory On Hand | 83.29 | 74.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for ARS Stock Analysis
When running ARS Pharmaceuticals' price analysis, check to measure ARS Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARS Pharmaceuticals is operating at the current time. Most of ARS Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ARS Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARS Pharmaceuticals' price. Additionally, you may evaluate how the addition of ARS Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.